UCB today announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XR™ (levetiracetam) extended-release tablets comparing tolerability vs. levetiracetam immediate release ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback